ChickP Protein (ChickP), the first in the world to launch the groundbreaking 90% chickpea isolate, has announced that it has successfully patented its plant-based protein solution in Israel. This milestone comes after an enduring journey of intensive research and development that began in 2015. Growthwell Group, a local investor in ChickP, is helping the company with its patent application in Singapore.
“Our successful patent application in Israel has been five years in the making,” says Ron Klein, CEO of ChickP. “We stand on the shoulders of researchers and food technologists, without whom this feat would not have been possible. We are excited to see how our partnership with Growthwell Group can take our market reach to the next level.”
The 90% chickpea isolate is developed by the faculty of Agriculture, Food and Environment of the Hebrew University of Jerusalem. Using state-of-the-art, patent-pending technology, the faculty is able to extract up to 90% pure plant protein out of the chickpea seed. As it contains all essential amino acids, the isolate is considered a complete protein. The isolate comes in powder form, making it an easy ingredient for food manufacturers to incorporate into their recipes.
Research has found that products containing the 90% chickpea isolate consistently excel in taste, texture and functionality. Furthermore, the chickpea proteins are allergen free and not genetically modified.
In addition, circa mid-November, ChickP launched its next-generation, non-GMO native starch. Due to its narrower granule-size distribution compared with those of pea and potato starches, ChickP Native Starch boasts better gelling and thickening properties. Hence, it is a great thickening or binding agent for soups, sauces, confectioneries, dairy, baked goods, desserts, meat and plant-based meat products. Not only that, its versatility makes it an excellent ingredient for extruded snacks or as an anti-caking agent for powdered blends such as instant soups, spices and premixes.
In 2020, ChickP began the commercial production of its 90% chickpea isolate. The pilot production saw a yield of 50 tonnes. By 2021, ChickP is set to augment its production capabilities, manufacturing over 1,000 tonnes of the isolate. This expansion will benefit even more food manufacturers who are keen on strengthening their portfolios of sustainable plant-based meats.
Growthwell, a leading manufacturer of plant-based alternatives for meat and seafood for the South East Asian market since 1989, is a significant shareholder of ChickP. It plans to open a state-of-the-art manufacturing plant in Singapore by 2021 Q2. The facility will have the latest food technology applications, high moisture extrusion (HME) capabilities and a fully automatic manufacturing production line to scale production and cater to the strong demand for plant-based meat and seafood alternatives in the region.
“The pandemic has put a crimp in our plans to launch the manufacturing plant this year,” says Justin Chou, second-generation leader and Executive Director of Growthwell Group. “But henceforth, it is full steam ahead. We are confident that the 90% chickpea isolate is the next frontier in plant-based meat. We are excited about supporting ChickP in its R&D journey as well as bringing alternative meat products made with chickpea proteins to the global stage.”
One innovative application of ChickP’s protein is in seafood and meat alternative products, through Texturised Vegetable Protein (TVP) and HME. Chickpea-based TVP/HME has clean label qualities and the potential to be a highly adaptable superfood with its several nutritional characteristics – high protein, high fibre, low carb and low sodium. With Chickpea-based TVP/HME, Growthwell is in its final round of researching and developing a chickpea protein-based seafood alternative collection – ChickP Squid, ChickP Crab Patty, and ChickP Shrimp – which will be free of allergens, gluten, lactose, and hormones, making it one of the safest proteins available for consumption.
With an established supply network in Asia Pacific, Growthwell is in a unique position to export these products to more than 10 different countries such as US, Spain, Indonesia, Malaysia and Australia.
全球首创推出90% 鹰嘴豆分离物品牌ChickP Protein (ChickP)，宣布在以色列成功为其植物性蛋白质方案申请到专利。工作团队从2015年起努力不懈密集研发，终于达到这一里程碑。ChickP的本地投资者Growthwell集团，正在协助公司申请新加坡专利。
11月中， ChickP 推出新一代的无转基因天然淀粉。由于其颗粒大小分布与豌豆和马铃薯淀粉相比更为狭窄，具有更好的胶凝和增稠特性，适合在多种食品应用中用作增稠剂或粘合剂，包括汤、酱料、糖果、乳制品、烘焙食品、甜点、肉类和植物肉。此外，也适用于膨化食品或作为粉状混合食品的抗结剂，如即饮汤品、香料、调料包。
2020年， ChickP 开始90%鹰嘴豆分离物的商业生产，首批产量为50公吨。到了2021年， ChickP 将提高生产能力，生产超过1000公吨的分离物。增加产量将使更多食品制造商都能够加强他们的永续植物性代替产品。
ChickP蛋白质的一项创新用途是通过组织化植物蛋白（TVP）和高水份挤压，制作海鲜与肉类代替品。鹰嘴豆基础的TVP/HME有天然产品标签的品质，有可能成为最灵活的超级食物，附有多种营养特色 – 高蛋白、高纤维、低淀粉、低钠。Growthwell目前正在使用ChickP的鹰嘴豆蛋白开发植物基海鲜系列产品，包括ChickP鱿鱼、ChickP虾和ChickP蟹肉饼等，全都不含过敏原、麸质、乳糖与荷尔蒙，成为最安全、最适合食用的蛋白质。